Works matching DE "ALCON Research Ltd."

Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 922, doi. 10.1038/nrd3063

Publication type:

Article